Anaphylaxis following quadrivalent human papillomavirus vaccination
JML Brotherton, MS Gold, AS Kemp, PB McIntyre… - CMAJ, 2008 - Can Med Assoc
Background: In 2007, Australia implemented the National human papillomavirus (HPV)
Vaccination Program, which provides quadrivalent HPV vaccine free to all women aged 12 …
Vaccination Program, which provides quadrivalent HPV vaccine free to all women aged 12 …
Hypersensitivity reactions to human papillomavirus vaccine in Australian schoolgirls: retrospective cohort study
Objective To describe the outcomes of clinical evaluation, skin testing, and vaccine
challenge in adolescent schoolgirls with suspected hypersensitivity to the quadrivalent …
challenge in adolescent schoolgirls with suspected hypersensitivity to the quadrivalent …
Coadministration of a 9-valent human papillomavirus vaccine with meningococcal and Tdap vaccines
A Schilling, MM Parra, M Gutierrez, J Restrepo… - …, 2015 - publications.aap.org
BACKGROUND: This study in 11-to 15-year-old boys and girls compared the
immunogenicity and safety of GARDASIL 9 (9-valent human papillomavirus [9vHPV] …
immunogenicity and safety of GARDASIL 9 (9-valent human papillomavirus [9vHPV] …
Systematic review of human papillomavirus vaccine coadministration
AS Noronha, LE Markowitz, EF Dunne - Vaccine, 2014 - Elsevier
Human papillomavirus (HPV) vaccination is recommended in early adolescence, at an age
when other vaccines are also recommended. Administration of multiple vaccines during one …
when other vaccines are also recommended. Administration of multiple vaccines during one …
[HTML][HTML] Safety of human papillomavirus vaccines: a review
KK Macartney, C Chiu, M Georgousakis… - Drug safety, 2013 - Springer
Vaccination to prevent human papillomavirus (HPV)-related infection leading to cancer,
particularly cervical cancer, is a major public health breakthrough. There are currently two …
particularly cervical cancer, is a major public health breakthrough. There are currently two …
Anaphylaxis as an adverse event following immunisation in the UK and Ireland
Anaphylaxis is a rare adverse event following immunisation (AEFI) and unlikely to be
detected in prelicensure vaccine trials. Previous retrospective studies have been hampered …
detected in prelicensure vaccine trials. Previous retrospective studies have been hampered …
HPV vaccine hesitancy: findings from a statewide survey of health care providers
AL McRee, MB Gilkey, AF Dempsey - Journal of Pediatric Health Care, 2014 - Elsevier
Introduction Health care provider recommendations are critical for human papillomavirus
(HPV) vaccine uptake. We sought to describe providers' HPV vaccine recommendation …
(HPV) vaccine uptake. We sought to describe providers' HPV vaccine recommendation …
Human papilloma virus immunization in adolescent and young adults: a cohort study to illustrate what events might be mistaken for adverse reactions
CA Siegrist, EM Lewis, J Eskola… - The Pediatric …, 2007 - journals.lww.com
Background: The large-scale implementation of human papilloma virus (HPV) immunization
will be followed by cases of autoimmune diseases occurring in temporal association with …
will be followed by cases of autoimmune diseases occurring in temporal association with …
Immunogenicity and safety of a mixed vaccination schedule with one dose of nonavalent and one dose of bivalent HPV vaccine versus two doses of nonavalent …
V Gilca, C Sauvageau, G Panicker, G De Serres… - Vaccine, 2018 - Elsevier
Background Limited data is available on the use of different HPV vaccines in the same
subjects. We evaluated the immunogenicity and safety of a mixed vaccination schedule with …
subjects. We evaluated the immunogenicity and safety of a mixed vaccination schedule with …
How much will it hurt? HPV vaccine side effects and influence on completion of the three-dose regimen
We examined the prevalence of reported pain following human papillomavirus (HPV)
vaccination and whether it differed from that for other adolescent vaccines or affected …
vaccination and whether it differed from that for other adolescent vaccines or affected …
